{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:16:43Z","timestamp":1740107803214,"version":"3.37.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T00:00:00Z","timestamp":1696464000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T00:00:00Z","timestamp":1696464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K08009"],"award-info":[{"award-number":["20K08009"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s10147-023-02418-7","type":"journal-article","created":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T19:01:57Z","timestamp":1696532517000},"page":"1607-1615","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical course of longer than five years after definitive radiotherapy for nasopharyngeal carcinoma"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3237-2119","authenticated-orcid":false,"given":"Hiroshi","family":"Doi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aritoshi","family":"Ri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Inada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saori","family":"Tatsuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Nakamatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Hosono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasumasa","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,5]]},"reference":[{"key":"2418_CR1","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1200\/JCO.20.03237","volume":"39","author":"YP Chen","year":"2021","unstructured":"Chen YP, Ismaila N, Chua MLK et al (2021) Chemotherapy in combination with radiotherapy for definitive-intent treatment of stage II-IVA nasopharyngeal carcinoma: CSCO and ASCO guideline. J Clin Oncol 39:840\u2013859. https:\/\/doi.org\/10.1200\/JCO.20.03237","journal-title":"J Clin Oncol"},{"key":"2418_CR2","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1007\/s10147-020-01665-2","volume":"25","author":"Y Nishimura","year":"2020","unstructured":"Nishimura Y, Ishikura S, Shibata T et al (2020) A phase II study of adaptive two-step intensity-modulated radiation therapy (IMRT) with chemotherapy for loco-regionally advanced nasopharyngeal cancer (JCOG1015). Int J Clin Oncol 25:1250\u20131259. https:\/\/doi.org\/10.1007\/s10147-020-01665-2","journal-title":"Int J Clin Oncol"},{"key":"2418_CR3","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1093\/jjco\/hyp136","volume":"40","author":"Y Nishimura","year":"2010","unstructured":"Nishimura Y, Shibata T, Nakamatsu K et al (2010) A two-step intensity-modulated radiation therapy method for nasopharyngeal cancer: The Kinki University experience. Jpn J Clin Oncol 40:130\u2013138. https:\/\/doi.org\/10.1093\/jjco\/hyp136","journal-title":"Jpn J Clin Oncol"},{"key":"2418_CR4","doi-asserted-by":"publisher","first-page":"4873","DOI":"10.1200\/JCO.2007.11.5501","volume":"25","author":"MKM Kam","year":"2007","unstructured":"Kam MKM, Leung SF, Zee B et al (2007) Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol 25:4873\u20134879. https:\/\/doi.org\/10.1200\/JCO.2007.11.5501","journal-title":"J Clin Oncol"},{"key":"2418_CR5","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.radonc.2014.02.003","volume":"110","author":"AW Lee","year":"2014","unstructured":"Lee AW, Ng WT, Chan LL et al (2014) Evolution of treatment for nasopharyngeal cancer\u2013success and setback in the intensity-modulated radiotherapy era. Radiother Oncol 110:377\u2013384. https:\/\/doi.org\/10.1016\/j.radonc.2014.02.003","journal-title":"Radiother Oncol"},{"key":"2418_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0219611","volume":"14","author":"T Du","year":"2019","unstructured":"Du T, Xiao J, Qiu Z et al (2019) The effectiveness of intensity-modulated radiation therapy versus 2D-RT for the treatment of nasopharyngeal carcinoma: a systematic review and meta-analysis. PLoS ONE 14:e0219611. https:\/\/doi.org\/10.1371\/journal.pone.0219611","journal-title":"PLoS ONE"},{"key":"2418_CR7","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1002\/hed.26634","volume":"43","author":"DMC Poon","year":"2021","unstructured":"Poon DMC, Kam MKM, Johnson D et al (2021) Durability of the parotid-sparing effect of intensity-modulated radiotherapy (IMRT) in early stage nasopharyngeal carcinoma: a 15-year follow-up of a randomized prospective study of IMRT versus two-dimensional radiotherapy. Head Neck 43:1711\u20131720. https:\/\/doi.org\/10.1002\/hed.26634","journal-title":"Head Neck"},{"key":"2418_CR8","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1634\/theoncologist.2017-0577","volume":"24","author":"L Chen","year":"2019","unstructured":"Chen L, Zhang Y, Lai SZ et al (2019) 10-year results of therapeutic ratio by intensity-modulated radiotherapy versus two-dimensional radiotherapy in patients with nasopharyngeal carcinoma. Oncologist 24:e38\u2013e45. https:\/\/doi.org\/10.1634\/theoncologist.2017-0577","journal-title":"Oncologist"},{"key":"2418_CR9","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1093\/annonc\/mdt163","volume":"24","author":"X Wu","year":"2013","unstructured":"Wu X, Huang PY, Peng PJ et al (2013) Long-term follow-up of a phase III study comparing radiotherapy with or without weekly oxaliplatin for locoregionally advanced nasopharyngeal carcinoma. Ann Oncol 24:2131\u20132136. https:\/\/doi.org\/10.1093\/annonc\/mdt163","journal-title":"Ann Oncol"},{"key":"2418_CR10","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1016\/j.ejca.2015.08.006","volume":"51","author":"MX Zhang","year":"2015","unstructured":"Zhang MX, Li J, Shen GP et al (2015) Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: a 10-year experience with a large cohort and long follow-up. Eur J Cancer 51:2587\u20132595. https:\/\/doi.org\/10.1016\/j.ejca.2015.08.006","journal-title":"Eur J Cancer"},{"key":"2418_CR11","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1186\/s12885-019-6156-5","volume":"19","author":"W Zhi-Qiang","year":"2019","unstructured":"Zhi-Qiang W, Qi M, Ji-Bin L et al (2019) The long-term survival of patients with III-IVb stage nasopharyngeal carcinoma treated with IMRT with or without Nimotuzumab: a propensity score-matched analysis. BMC Cancer 19:1122","journal-title":"BMC Cancer"},{"key":"2418_CR12","doi-asserted-by":"publisher","first-page":"267","DOI":"10.7150\/ijms.68394","volume":"19","author":"X Niu","year":"2022","unstructured":"Niu X, Xue F, Liu P et al (2022) Long-term outcomes of nasopharyngea carcinoma patients with T1\u20132 stage in intensity-modulated radiotherapy era. Int J Med Sci 19:267\u2013273. https:\/\/doi.org\/10.7150\/ijms.68394","journal-title":"Int J Med Sci"},{"key":"2418_CR13","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.radonc.2020.08.015","volume":"151","author":"N Kanayama","year":"2020","unstructured":"Kanayama N, Otozai S, Yoshii T et al (2020) Death unrelated to cancer and death from aspiration pneumonia after definitive radiotherapy for head and neck cancer. Radiother Oncol 151:266\u2013272. https:\/\/doi.org\/10.1016\/j.radonc.2020.08.015","journal-title":"Radiother Oncol"},{"key":"2418_CR14","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1200\/JCO.2006.06.0079","volume":"24","author":"DI Rosenthal","year":"2006","unstructured":"Rosenthal DI, Lewin JS, Eisbruch A (2006) Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer. J Clin Oncol 24:2636\u20132643. https:\/\/doi.org\/10.1200\/JCO.2006.06.0079","journal-title":"J Clin Oncol"},{"key":"2418_CR15","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1186\/s12885-016-2813-0","volume":"16","author":"I Petkar","year":"2016","unstructured":"Petkar I, Rooney K, Roe JWG et al (2016) DARS: A phase III randomised multicentre study of dysphagia-optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancer. BMC Cancer 16:770. https:\/\/doi.org\/10.1186\/s12885-016-2813-0","journal-title":"BMC Cancer"},{"key":"2418_CR16","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1080\/0284186X.2021.2022198","volume":"61","author":"MG Ashour","year":"2022","unstructured":"Ashour MG, Shouman TH, Hassouna AH et al (2022) Swallowing sparing intensity modulated radiotherapy versus standard parotid sparing intensity-modulated radiotherapy for treatment of head and neck cancer: a randomized clinical trial. Acta Oncol 61:134\u2013140. https:\/\/doi.org\/10.1080\/0284186X.2021.2022198","journal-title":"Acta Oncol"},{"key":"2418_CR17","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/hed.26016","volume":"42","author":"A Coca-Pelaz","year":"2020","unstructured":"Coca-Pelaz A, Rodrigo JP, Su\u00e1rez C et al (2020) The risk of second primary tumors in head and neck cancer: a systematic review. Head Neck 42:456\u2013466. https:\/\/doi.org\/10.1002\/hed.26016","journal-title":"Head Neck"},{"key":"2418_CR18","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/1097-0215(20000715)87:2<228::aid-ijc12>3.0.co;2-t","volume":"87","author":"CC Wang","year":"2000","unstructured":"Wang CC, Chen ML, Hsu KH et al (2000) Second malignant tumors in patients with nasopharyngeal carcinoma and their association with Epstein-Barr virus. Int J Cancer 87:228\u2013231. https:\/\/doi.org\/10.1002\/1097-0215(20000715)87:2%3c228::aid-ijc12%3e3.0.co;2-t","journal-title":"Int J Cancer"},{"key":"2418_CR19","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1002\/cncr.22119","volume":"107","author":"L Kong","year":"2006","unstructured":"Kong L, Lu JJ, Hu C et al (2006) The risk of second primary tumors in patients with nasopharyngeal carcinoma after definitive radiotherapy. Cancer 107:1287\u20131293. https:\/\/doi.org\/10.1002\/cncr.22119","journal-title":"Cancer"},{"key":"2418_CR20","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.3389\/fonc.2020.01469","volume":"10","author":"F Li","year":"2020","unstructured":"Li F, Chen FP, Chen YP et al (2020) Clinical characteristics and prognostic factors of early and late recurrence after definitive radiotherapy for nasopharyngeal carcinoma. Front Oncol 10:1469. https:\/\/doi.org\/10.3389\/fonc.2020.01469","journal-title":"Front Oncol"},{"key":"2418_CR21","doi-asserted-by":"publisher","first-page":"795S","DOI":"10.1177\/0145561320908955","volume":"100","author":"N Toumi","year":"2021","unstructured":"Toumi N, Ennouri S, Charfeddine I et al (2021) Local and lymph node relapse of nasopharyngeal carcinoma: a single-center experience. Ear Nose Throat J 100:795S-800S. https:\/\/doi.org\/10.1177\/0145561320908955","journal-title":"Ear Nose Throat J"},{"key":"2418_CR22","volume-title":"TNM classification of malignant tumours","author":"JD Brierley","year":"2017","unstructured":"Brierley JD, Gospodarowicz MK, Wittekind C (2017) TNM classification of malignant tumours. Wiley, Hoboken"},{"key":"2418_CR23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s10147-016-1034-5","volume":"22","author":"T Matsuura","year":"2017","unstructured":"Matsuura T, Nishimura Y, Nakamatsu K et al (2017) Clinical outcomes of IMRT planned with or without PET\/CT simulation for patients with pharyngeal cancers. Int J Clin Oncol 22:52\u201358. https:\/\/doi.org\/10.1007\/s10147-016-1034-5","journal-title":"Int J Clin Oncol"},{"key":"2418_CR24","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE), v.5.0. https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/ctcae_v5_quick_reference_5x7.pdf. Accessed Dec 24, 2021"},{"key":"2418_CR25","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/cncr.10668","volume":"95","author":"YS Lin","year":"2002","unstructured":"Lin YS, Jen YM, Lin JC (2002) Radiation-related cranial nerve palsy in patients with nasopharyngeal carcinoma. Cancer 95:404\u2013409. https:\/\/doi.org\/10.1002\/cncr.10668","journal-title":"Cancer"},{"key":"2418_CR26","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.meddos.2020.07.002","volume":"46","author":"JCH Chow","year":"2021","unstructured":"Chow JCH, Lui JCF, Au KH et al (2021) Application of hypoglossal nerve constraint in definitive radiotherapy for nasopharyngeal carcinoma: a dosimetric feasibility study. Med Dosim 46:39\u201344. https:\/\/doi.org\/10.1016\/j.meddos.2020.07.002","journal-title":"Med Dosim"},{"key":"2418_CR27","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1177\/000348949910800614","volume":"108","author":"S P\u00e9ri\u00e9","year":"1999","unstructured":"P\u00e9ri\u00e9 S, Coiffier L, Laccourreye L et al (1999) Swallowing disorders in paralysis of the lower cranial nerves: a functional analysis. Ann Otol Rhinol Laryngol 108:606\u2013611. https:\/\/doi.org\/10.1177\/000348949910800614","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"2418_CR28","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/j.ijrobp.2004.05.050","volume":"60","author":"A Eisbruch","year":"2004","unstructured":"Eisbruch A, Schwartz M, Rasch C et al (2004) Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT? Int J Radiat Oncol Biol Phys 60:1425\u20131439. https:\/\/doi.org\/10.1016\/j.ijrobp.2004.05.050","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2418_CR29","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1148\/rg.2021200171","volume":"41","author":"L Khanna","year":"2021","unstructured":"Khanna L, Prasad SR, Yedururi S et al (2021) Second malignancies after radiation therapy: Update on pathogenesis and cross-sectional imaging findings. Radiographics 41:876\u2013894. https:\/\/doi.org\/10.1148\/rg.2021200171","journal-title":"Radiographics"},{"key":"2418_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijrobp.2006.01.027","volume":"65","author":"EJ Hall","year":"2006","unstructured":"Hall EJ (2006) Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys 65:1\u20137. https:\/\/doi.org\/10.1016\/j.ijrobp.2006.01.027","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2418_CR31","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1158\/1055-9965.EPI-08-0461","volume":"17","author":"F Bray","year":"2008","unstructured":"Bray F, Haugen M, Moger TA et al (2008) Age-incidence curves of nasopharyngeal carcinoma worldwide: bimodality in low-risk populations and aetiologic implications. Cancer Epidemiol Biomarkers Prev 17:2356\u20132365. https:\/\/doi.org\/10.1158\/1055-9965.EPI-08-0461","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"2418_CR32","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41698-019-0097-y","volume":"27","author":"SP Ng","year":"2019","unstructured":"Ng SP, Pollard C 3rd, Kamal M et al (2019) Risk of second primary malignancies in head and neck cancer patients treated with definitive radiotherapy. NPJ Precis Oncol 27(3):22. https:\/\/doi.org\/10.1038\/s41698-019-0097-y","journal-title":"NPJ Precis Oncol"},{"key":"2418_CR33","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1093\/annonc\/mdn003","volume":"19","author":"M-C Chen","year":"2008","unstructured":"Chen M-C, Feng I-J, Lu C-H et al (2008) The incidence and risk of second primary cancers in patients with nasopharyngeal carcinoma: a population-based study in Taiwan over a 25-year period (1979\u20132003). Ann Oncol 19:1180\u20131186. https:\/\/doi.org\/10.1093\/annonc\/mdn003","journal-title":"Ann Oncol"},{"key":"2418_CR34","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1200\/jco.2010.31.8311","volume":"29","author":"LGT Morris","year":"2011","unstructured":"Morris LGT, Sikora AG, Patel SG et al (2011) Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer. J Clin Oncol 29:739\u2013746. https:\/\/doi.org\/10.1200\/jco.2010.31.8311","journal-title":"J Clin Oncol"},{"key":"2418_CR35","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1001\/jamaoto.2018.0993","volume":"144","author":"EA Boakye","year":"2018","unstructured":"Boakye EA, Buchanan P, Hinyard L et al (2018) Incidence and risk of second primary malignant neoplasm after a first head and neck squamous cell carcinoma. JAMA Otolaryngol Head Neck Surg 144:727\u2013737. https:\/\/doi.org\/10.1001\/jamaoto.2018.0993","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"2418_CR36","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1007\/s11912-022-01263-7","volume":"24","author":"P Goon","year":"2022","unstructured":"Goon P, Sch\u00fcrmann M, Oppel F et al (2022) Viral and clinical oncology of head and neck cancers. Curr Oncol Rep 24:929\u2013942. https:\/\/doi.org\/10.1007\/s11912-022-01263-7","journal-title":"Curr Oncol Rep"},{"key":"2418_CR37","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/S1470-2045(18)30931-8","volume":"20","author":"O Mohamand","year":"2019","unstructured":"Mohamand O, Tabuchi T, Nitta Y et al (2019) Risk of subsequent primary cancers after carbon ion radiotherapy, photon radiotherapy, or surgery for localised prostate cancer: a propensity score-weighted, retrospective, cohort study. Lancet Oncol 20:674\u2013685. https:\/\/doi.org\/10.1016\/S1470-2045(18)30931-8","journal-title":"Lancet Oncol"},{"key":"2418_CR38","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1093\/jjco\/hyx190","volume":"48","author":"C Hamashima","year":"2018","unstructured":"Hamashima C (2018) Cancer screening guidelines and policy making: 15 years of experience in cancer screening guideline development in Japan. Jpn J Clin Oncol 48:278\u2013286. https:\/\/doi.org\/10.1093\/jjco\/hyx190","journal-title":"Jpn J Clin Oncol"},{"key":"2418_CR39","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) Head and Neck Cancer Version 1. 2023 https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/head-and-neck.pdf. Accessed March 23, 2023"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-023-02418-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-023-02418-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-023-02418-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T04:31:10Z","timestamp":1701318670000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-023-02418-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,5]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["2418"],"URL":"https:\/\/doi.org\/10.1007\/s10147-023-02418-7","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"type":"print","value":"1341-9625"},{"type":"electronic","value":"1437-7772"}],"subject":[],"published":{"date-parts":[[2023,10,5]]},"assertion":[{"value":"23 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}